2023-11-15 Purchase | 2023-11-17 4:33 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P TCG Opportunity III GP LLC Director 10% Owner | 22,631 | $0.6852 | $15,507 | 21,743,413 (Indirect Direct) | View |
2023-11-15 Purchase | 2023-11-17 4:30 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Column Group Opportunity III LP Column Group Opportunity III GP LP Director 10% Owner | 22,631 | $0.6852 | $15,507 | 21,743,413 (Indirect Direct) | View |
2023-11-15 Purchase | 2023-11-17 4:28 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P Svennilson Peter Kutzkey Tim Ponoi Capital II LP Ponoi II Management LLC PONOI CAPITAL LP Ponoi Management LLC COLUMN GROUP II LP Column Group Management LP Column Group II GP LP Director 10% Owner | 22,631 | $0.6852 | $15,507 | 21,743,413 (Indirect Direct) | View |
2023-01-30 Purchase | 2023-02-01 4:50 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Column Group Opportunity III LP Column Group Opportunity III GP LP Director 10% Owner | 184,272 | $4.9986 | $921,110 | 21,720,782 (Indirect Direct) | View |
2023-01-30 Purchase | 2023-02-01 4:31 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P TCG Opportunity III GP LLC Director 10% Owner | 184,272 | $4.9986 | $921,110 | 21,720,782 (Indirect Direct) | View |
2023-01-30 Purchase | 2023-02-01 4:29 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P Svennilson Peter Kutzkey Tim Ponoi Capital II LP Ponoi II Management LLC PONOI CAPITAL LP Ponoi Management LLC COLUMN GROUP II LP Column Group Management LP Column Group II GP LP Director 10% Owner | 184,272 | $4.9986 | $921,110 | 21,720,782 (Indirect Direct) | View |
2023-01-23 Purchase | 2023-01-25 4:38 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P TCG Opportunity III GP LLC Director 10% Owner | 9,900 | $4.9994 | $49,494 | 21,536,510 (Indirect Direct) | View |
2023-01-23 Purchase | 2023-01-25 4:35 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Column Group Opportunity III LP Column Group Opportunity III GP LP Director 10% Owner | 9,900 | $4.9994 | $49,494 | 21,536,510 (Indirect Direct) | View |
2023-01-23 Purchase | 2023-01-25 4:31 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P Svennilson Peter Kutzkey Tim Ponoi Capital II LP Ponoi II Management LLC PONOI CAPITAL LP Ponoi Management LLC COLUMN GROUP II LP Column Group Management LP Column Group II GP LP Director 10% Owner | 9,900 | $4.9994 | $49,494 | 21,536,510 (Indirect Direct) | View |
2023-01-19 Purchase | 2023-01-23 4:25 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P TCG Opportunity III GP LLC Director 10% Owner | 38,139 | $4.9976 | $190,603 | 21,526,610 (Indirect Direct) | View |
2023-01-19 Purchase | 2023-01-23 4:22 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Column Group Opportunity III LP Column Group Opportunity III GP LP Director 10% Owner | 38,139 | $4.9976 | $190,603 | 21,526,610 (Indirect Direct) | View |
2023-01-19 Purchase | 2023-01-23 4:19 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P Svennilson Peter Kutzkey Tim Ponoi Capital II LP Ponoi II Management LLC PONOI CAPITAL LP Ponoi Management LLC COLUMN GROUP II LP Column Group Management LP Column Group II GP LP Director 10% Owner | 38,139 | $4.9976 | $190,603 | 21,526,610 (Indirect Direct) | View |
2023-01-12 Purchase | 2023-01-17 4:36 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P TCG Opportunity III GP LLC Director 10% Owner | 5,378 | $4.9466 | $26,603 | 21,488,471 (Indirect Direct) | View |
2023-01-12 Purchase | 2023-01-17 4:34 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Column Group Opportunity III LP Column Group Opportunity III GP LP Director 10% Owner | 5,378 | $4.9466 | $26,603 | 21,488,471 (Indirect Direct) | View |
2023-01-12 Purchase | 2023-01-17 4:32 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P Svennilson Peter Kutzkey Tim Ponoi Capital II LP Ponoi II Management LLC PONOI CAPITAL LP Ponoi Management LLC COLUMN GROUP II LP Column Group Management LP Column Group II GP LP Director 10% Owner | 5,378 | $4.9466 | $26,603 | 21,488,471 (Indirect Direct) | View |
2023-01-10 Purchase | 2023-01-12 4:40 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P TCG Opportunity III GP LLC Director 10% Owner | 309,070 | $4.7865 | $1,479,359 | 21,483,093 (Indirect Direct) | View |
2023-01-10 Purchase | 2023-01-12 4:37 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Column Group Opportunity III LP Column Group Opportunity III GP LP Director 10% Owner | 309,070 | $4.7865 | $1,479,359 | 21,483,093 (Indirect Direct) | View |
2023-01-10 Purchase | 2023-01-12 4:35 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P Svennilson Peter Kutzkey Tim Ponoi Capital II LP Ponoi II Management LLC PONOI CAPITAL LP Ponoi Management LLC COLUMN GROUP II LP Column Group Management LP Column Group II GP LP Director 10% Owner | 309,070 | $4.7865 | $1,479,359 | 21,483,093 (Indirect Direct) | View |
2022-12-12 Purchase | 2022-12-14 4:31 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P TCG Opportunity III GP LLC Director 10% Owner | 300 | $4.9767 | $1,493 | 21,174,023 (Indirect Direct) | View |
2022-12-12 Purchase | 2022-12-14 4:29 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Column Group Opportunity III LP Column Group Opportunity III GP LP Director 10% Owner | 300 | $4.9767 | $1,493 | 21,174,023 (Indirect Direct) | View |
2022-12-12 Purchase | 2022-12-14 4:28 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P Svennilson Peter Kutzkey Tim Ponoi Capital II LP Ponoi II Management LLC PONOI CAPITAL LP Ponoi Management LLC COLUMN GROUP II LP Column Group Management LP Column Group II GP LP Director 10% Owner | 300 | $4.9767 | $1,493 | 21,174,023 (Indirect Direct) | View |
2022-11-21 Purchase | 2022-11-23 4:21 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P TCG Opportunity III GP LLC Director 10% Owner | 40,327 | $4.9988 | $201,588 | 21,173,723 (Indirect Direct) | View |
2022-11-21 Purchase | 2022-11-23 4:17 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Column Group Opportunity III LP Column Group Opportunity III GP LP Director 10% Owner | 40,327 | $4.9988 | $201,588 | 21,173,723 (Indirect Direct) | View |
2022-11-21 Purchase | 2022-11-23 4:14 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P Svennilson Peter Kutzkey Tim Ponoi Capital II LP Ponoi II Management LLC PONOI CAPITAL LP Ponoi Management LLC COLUMN GROUP II LP Column Group Management LP Column Group II GP LP Director 10% Owner | 40,327 | $4.9988 | $201,588 | 21,173,723 (Indirect Direct) | View |
2022-11-03 Purchase | 2022-11-07 4:30 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P TCG Opportunity III GP LLC Director 10% Owner | 139,148 | $4.9187 | $684,427 | 21,133,396 (Indirect Direct) | View |
2022-11-03 Purchase | 2022-11-07 4:20 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Column Group Opportunity III LP Column Group Opportunity III GP LP Director 10% Owner | 139,148 | $4.9187 | $684,427 | 21,133,396 (Indirect Direct) | View |
2022-11-03 Purchase | 2022-11-07 4:17 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P Svennilson Peter Kutzkey Tim Ponoi Capital II LP Ponoi II Management LLC PONOI CAPITAL LP Ponoi Management LLC COLUMN GROUP II LP Column Group Management LP Column Group II GP LP Director 10% Owner | 139,148 | $4.9187 | $684,427 | 21,133,396 (Indirect Direct) | View |
2022-10-27 Purchase | 2022-10-31 5:20 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P TCG Opportunity III GP LLC Director 10% Owner | 76,877 | $4.8602 | $373,638 | 20,994,248 (Indirect Direct) | View |
2022-10-27 Purchase | 2022-10-31 5:19 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Column Group Opportunity III LP Column Group Opportunity III GP LP Director 10% Owner | 76,877 | $4.8602 | $373,638 | 20,994,248 (Indirect Direct) | View |
2022-10-27 Purchase | 2022-10-31 5:17 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P Svennilson Peter Kutzkey Tim Ponoi Capital II LP Ponoi II Management LLC PONOI CAPITAL LP Ponoi Management LLC COLUMN GROUP II LP Column Group Management LP Column Group II GP LP Director 10% Owner | 76,877 | $4.8602 | $373,638 | 20,994,248 (Indirect Direct) | View |
2022-10-25 Purchase | 2022-10-27 6:58 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P TCG Opportunity III GP LLC Director 10% Owner | 123,820 | $4.8088 | $595,428 | 20,917,371 (Indirect Direct) | View |
2022-10-25 Purchase | 2022-10-27 6:55 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Column Group Opportunity III LP Column Group Opportunity III GP LP Director 10% Owner | 123,820 | $4.8088 | $595,428 | 20,917,371 (Indirect Direct) | View |
2022-10-25 Purchase | 2022-10-27 6:50 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P Svennilson Peter Kutzkey Tim Ponoi Capital II LP Ponoi II Management LLC PONOI CAPITAL LP Ponoi Management LLC COLUMN GROUP II LP Column Group Management LP Column Group II GP LP Director 10% Owner | 123,820 | $4.8088 | $595,428 | 20,917,371 (Indirect Direct) | View |
2022-06-09 Purchase | 2022-06-13 5:05 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Director 10% Owner | 984,161 | $13.5 | $13,286,174 | 18,143,374 (Indirect Direct) | View |
2022-06-09 Purchase | 2022-06-13 4:58 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P Svennilson Peter Kutzkey Tim Ponoi Capital II LP Ponoi II Management LLC PONOI CAPITAL LP Ponoi Management LLC COLUMN GROUP II LP Column Group Management LP Column Group II GP LP Director 10% Owner | 984,161 | $13.5 | $13,286,174 | 18,143,374 (Indirect Direct) | View |
2022-06-02 Purchase | 2022-06-06 4:44 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Director 10% Owner | 34,200 | $13.03 | $445,739 | 18,110,897 (Indirect Direct) | View |
2022-06-02 Purchase | 2022-06-06 4:43 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P Svennilson Peter Kutzkey Tim Ponoi Capital II LP Ponoi II Management LLC PONOI CAPITAL LP Ponoi Management LLC COLUMN GROUP II LP Column Group Management LP Column Group II GP LP Director 10% Owner | 34,200 | $13.03 | $445,739 | 18,110,897 (Indirect Direct) | View |
2022-05-31 Purchase | 2022-06-02 4:28 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Director 10% Owner | 153,806 | $13.46 | $2,069,667 | 18,109,768 (Indirect Direct) | View |
2022-05-31 Purchase | 2022-06-02 4:26 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P Svennilson Peter Kutzkey Tim Ponoi Capital II LP Ponoi II Management LLC PONOI CAPITAL LP Ponoi Management LLC COLUMN GROUP II LP Column Group Management LP Column Group II GP LP Director 10% Owner | 153,806 | $13.46 | $2,069,667 | 18,109,768 (Indirect Direct) | View |